Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug–coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT
British Journal of Surgery · 2025
DOI: 10.1093/bjs/znaf251 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, 2025. Verfasst von Matthew Popplewell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Black Country Vascular Network, Dudley Group of Hospitals, Dudley, UK. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Angioplasty, Balloon, Popliteal Artery, Paclitaxel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK National Institute of Health Research, Health Technology Assessment.
Abstract (Originalsprache)
Introduction
In recent years there have been a plethora of new endovascular devices have entered the market, including paclitaxel (PTX) drug-coated balloons (DCB) and drug-eluting stents (DES) for treating patients with chronic limb-threatening ischaemia (CLTI). There have been concerns that the use of PTX is associated with increased all-cause mortality rate in this patient population.
Methods
In the BASIL-3 trial (ISRCTN14469736) UK patients with CLTI were randomized (1:1:1) to receive femoro-popliteal (FP) plain balloon angioplasty (PBA; with or without bailout bare metal stenting (BMS), DCB angioplasty (DCBA) (with or without BMS), or primary DES. Here, data from the DCBA and DES arms have been pooled into a single ‘drug technologies’ (DT) group and compared with PBA ± BMS. The primary outcome was overall survival (OS). Secondary outcomes included amputation-free survival (AFS), major amputations, major adverse limb events, major adverse cardiovascular events, reinterventions, and 30-day mortality and morbidity rates.
Results
Four hundred and eighty-one participants were randomized (PBA: n = 160; DT: n = 321). At a median follow-up in survivors of 5.6 years, OS was similar between the pooled DT and PBA groups (adjusted hazard ratio (HR): 0.83; 95% c.i.: 0.64 to 1.07). There was no evidence of a statistically significant difference in AFS between the groups (adjusted HR: 0.84; 95% c.i.: 0.66 to 1.06), or other secondary outcomes.
Conclusions
This further pooled analysis of the BASIL-3 RCT does not support the notion that the use of drug-eluting technologies, when compared to plain balloon angioplasty, increases all-cause mortality rate, or has other clinically important adverse effects, when used in patients with CLTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Black Country Vascular Network, Dudley Group of Hospitals, Dudley, UK.
- Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.
- Birmingham Clinical Trials Unit, Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.
- Department of Vascular Surgery, University Hospital of Wales, Cardiff, UK.
- Department of Vascular Surgery,University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- Department of Vascular Surgery, University of Birmingham, Birmingham, UK.
ORCID-Profile: Matthew Popplewell, Jack Hall, Lewis Meecham, Gareth Bate, Lisa Kelly, Jon J Deeks, Catherine A Moakes, Andrew Bradbury
Förderung
- UK National Institute of Health Research
- Health Technology Assessment
Zitieren
APA
Popplewell, M., Hall, J., Meecham, L., Bate, G., Kelly, L., Deeks, J. J., Moakes, C. A., Bradbury, A., & BASIL-3 Investigators (2025). Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug–coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT. British Journal of Surgery. https://doi.org/10.1093/bjs/znaf251
Vancouver
Popplewell M, Hall J, Meecham L, Bate G, Kelly L, Deeks JJ, et al. Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug–coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT. British Journal of Surgery. 2025. doi:10.1093/bjs/znaf251
BibTeX
@article{Popplewell2025,
author = {Popplewell, Matthew and Hall, Jack and Meecham, Lewis and Bate, Gareth and Kelly, Lisa and Deeks, Jon J and Moakes, Catherine A and Bradbury, Andrew and BASIL-3 Investigators, BASIL-3 Investigators},
title = {Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug–coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT},
journal = {British Journal of Surgery},
year = {2025},
doi = {10.1093/bjs/znaf251}
}
EUVIMED